Cargando…

Advances in the application of Let-7 microRNAs in the diagnosis, treatment and prognosis of leukemia

The lethal-7 (Let-7) family of microRNAs (miRNAs) controls the process of development and differentiation, but is also related to the occurrence of tumors and a poor prognosis of patients with tumors. Thus, a more comprehensive exploration of its functions will provide further insights into these pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Hao, Wang, Jiewei, Wang, Huan, Liang, Jingru, Dong, Jinhua, Bai, Houqiao, Jiang, Guosheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8607238/
https://www.ncbi.nlm.nih.gov/pubmed/34820000
http://dx.doi.org/10.3892/ol.2021.13119
_version_ 1784602522271350784
author Chen, Hao
Wang, Jiewei
Wang, Huan
Liang, Jingru
Dong, Jinhua
Bai, Houqiao
Jiang, Guosheng
author_facet Chen, Hao
Wang, Jiewei
Wang, Huan
Liang, Jingru
Dong, Jinhua
Bai, Houqiao
Jiang, Guosheng
author_sort Chen, Hao
collection PubMed
description The lethal-7 (Let-7) family of microRNAs (miRNAs) controls the process of development and differentiation, but is also related to the occurrence of tumors and a poor prognosis of patients with tumors. Thus, a more comprehensive exploration of its functions will provide further insights into these processes, and may promote the diagnosis and treatment of tumors. Leukemia is a type of progressive malignant disease, and its pathogenesis involves a variety of epigenetic factors. Amongst the several related epigenetic factors, the Let-7 miRNAs are an important family of molecules that play a crucial role in maintaining a variety of critical biological processes, including development, differentiation and proliferation. In the present study, the role of Let-7 as a tumor suppressor gene and oncogene is reviewed, and the complex regulatory functions of several Let-7 family members in different subtypes of leukemia are described. The current body of knowledge thus far indicates that Let-7 is not only a potential diagnostic and prognostic marker of leukemia, but also a potential therapeutic target for the treatment of affected patients, with particular potential when targeted by adjuvant treatments alongside traditional treatment to improve their survival rate.
format Online
Article
Text
id pubmed-8607238
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher D.A. Spandidos
record_format MEDLINE/PubMed
spelling pubmed-86072382021-11-23 Advances in the application of Let-7 microRNAs in the diagnosis, treatment and prognosis of leukemia Chen, Hao Wang, Jiewei Wang, Huan Liang, Jingru Dong, Jinhua Bai, Houqiao Jiang, Guosheng Oncol Lett Review The lethal-7 (Let-7) family of microRNAs (miRNAs) controls the process of development and differentiation, but is also related to the occurrence of tumors and a poor prognosis of patients with tumors. Thus, a more comprehensive exploration of its functions will provide further insights into these processes, and may promote the diagnosis and treatment of tumors. Leukemia is a type of progressive malignant disease, and its pathogenesis involves a variety of epigenetic factors. Amongst the several related epigenetic factors, the Let-7 miRNAs are an important family of molecules that play a crucial role in maintaining a variety of critical biological processes, including development, differentiation and proliferation. In the present study, the role of Let-7 as a tumor suppressor gene and oncogene is reviewed, and the complex regulatory functions of several Let-7 family members in different subtypes of leukemia are described. The current body of knowledge thus far indicates that Let-7 is not only a potential diagnostic and prognostic marker of leukemia, but also a potential therapeutic target for the treatment of affected patients, with particular potential when targeted by adjuvant treatments alongside traditional treatment to improve their survival rate. D.A. Spandidos 2022-01 2021-11-02 /pmc/articles/PMC8607238/ /pubmed/34820000 http://dx.doi.org/10.3892/ol.2021.13119 Text en Copyright: © Chen et al. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
spellingShingle Review
Chen, Hao
Wang, Jiewei
Wang, Huan
Liang, Jingru
Dong, Jinhua
Bai, Houqiao
Jiang, Guosheng
Advances in the application of Let-7 microRNAs in the diagnosis, treatment and prognosis of leukemia
title Advances in the application of Let-7 microRNAs in the diagnosis, treatment and prognosis of leukemia
title_full Advances in the application of Let-7 microRNAs in the diagnosis, treatment and prognosis of leukemia
title_fullStr Advances in the application of Let-7 microRNAs in the diagnosis, treatment and prognosis of leukemia
title_full_unstemmed Advances in the application of Let-7 microRNAs in the diagnosis, treatment and prognosis of leukemia
title_short Advances in the application of Let-7 microRNAs in the diagnosis, treatment and prognosis of leukemia
title_sort advances in the application of let-7 micrornas in the diagnosis, treatment and prognosis of leukemia
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8607238/
https://www.ncbi.nlm.nih.gov/pubmed/34820000
http://dx.doi.org/10.3892/ol.2021.13119
work_keys_str_mv AT chenhao advancesintheapplicationoflet7micrornasinthediagnosistreatmentandprognosisofleukemia
AT wangjiewei advancesintheapplicationoflet7micrornasinthediagnosistreatmentandprognosisofleukemia
AT wanghuan advancesintheapplicationoflet7micrornasinthediagnosistreatmentandprognosisofleukemia
AT liangjingru advancesintheapplicationoflet7micrornasinthediagnosistreatmentandprognosisofleukemia
AT dongjinhua advancesintheapplicationoflet7micrornasinthediagnosistreatmentandprognosisofleukemia
AT baihouqiao advancesintheapplicationoflet7micrornasinthediagnosistreatmentandprognosisofleukemia
AT jiangguosheng advancesintheapplicationoflet7micrornasinthediagnosistreatmentandprognosisofleukemia